Itron (NASDAQ:ITRI) Announces Quarterly Earnings Results

Itron (NASDAQ:ITRI) announced its quarterly earnings results on Tuesday. The scientific and technical instruments company reported $2.46 EPS for the quarter, beating the consensus estimate of $2.19 by $0.27, Briefing.com reports. The company had revenue of $571.66 million for the quarter, compared to analyst estimates of $561.31 million. Itron had a net margin of 10.69% and a return on equity of 17.82%. Itron’s revenue was down 6.7% compared to the same quarter last year. During the same quarter last year, the business earned $1.35 earnings per share. Itron updated its Q1 2026 guidance to 1.200-1.300 EPS and its FY 2026 guidance to 5.750-6.250 EPS.

Here are the key takeaways from Itron’s conference call:

• Itron reported a strong quarter with Q4 revenue $572M, record adjusted EBITDA of $99M, non-GAAP EPS of $2.46, and free cash flow of $112M, highlighting improved margins and execution.
• Demand indicators were constructive—Q4 bookings of $737M, total backlog of $4.5B, Outcomes backlog above $1B, and annual recurring revenue (ARR) of $368M (up ~20% Y/Y).
• Itron closed acquisitions of Urbint and Locusview, launching a new Resiliency Solutions segment expected to add ~$65–70M revenue in 2026 with ~70% gross margins, expanding lifecycle offerings but bringing integration and near-term execution considerations.
• 2026 outlook is modest—revenue guidance of $2.35B–$2.45B (midpoint ~1% growth) and non-GAAP EPS of $5.75–$6.25, where acquisitions create an expected ~$0.38 EPS headwind in 2026 and Q1 guidance implies a ~6% revenue decline y/y.

Itron Stock Up 7.9%

NASDAQ:ITRI opened at $96.43 on Wednesday. The business’s fifty day moving average price is $97.61 and its 200 day moving average price is $110.47. The firm has a market capitalization of $4.42 billion, a price-to-earnings ratio of 17.34, a PEG ratio of 0.51 and a beta of 1.48. The company has a current ratio of 2.17, a quick ratio of 1.91 and a debt-to-equity ratio of 0.46. Itron has a 1-year low of $88.57 and a 1-year high of $142.00.

Wall Street Analyst Weigh In

ITRI has been the subject of a number of recent analyst reports. Stephens upgraded shares of Itron from an “equal weight” rating to an “overweight” rating and set a $130.00 target price for the company in a research report on Monday, November 3rd. Johnson Rice upgraded shares of Itron from an “accumulate” rating to a “buy” rating and set a $130.00 price objective on the stock in a research note on Monday, January 5th. Argus reissued a “hold” rating on shares of Itron in a report on Tuesday, November 4th. Guggenheim set a $155.00 price target on Itron in a research note on Friday. Finally, Robert W. Baird set a $128.00 price objective on Itron in a research note on Wednesday. Seven investment analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $137.10.

Key Headlines Impacting Itron

Here are the key news stories impacting Itron this week:

• Positive Sentiment: Q4 results beat on both EPS and revenue, with non‑GAAP EPS of $2.46 vs. $2.19 expected, improved gross margins and strong free cash flow (Q4 FCF $112M; FY2025 FCF $383M) — a key driver of today’s bullish move. Itron shares rise after Q4 profit surge, strong cash flow, and 2026 outlook
• Positive Sentiment: Backlog and M&A support: year‑end backlog reported at ~$4.5B and recent acquisitions (Urbint, Locusview) are positioned to expand software/recurring revenue, which investors favor for higher-margin, predictable cash flows. Itron Announces Fourth Quarter and Full Year 2025 Financial Results
• Neutral Sentiment: Media/analyst attention lifted sentiment — several outlets and transcripts highlighting the outperformance and margin trends, helping momentum even as some metrics are mixed. Why Itron Stock Is Skyrocketing Today
• Negative Sentiment: Guidance came in light of Street expectations: Q1 FY2026 non‑GAAP EPS $1.20–1.30 vs. consensus ~1.36, and Q1 revenue $565–575M vs. ~$593M expected; FY2026 EPS range $5.75–6.25 was slightly under the ~5.89 consensus — a near‑term dampener on expectations. Itron press release / guidance
• Negative Sentiment: Softer bookings and slower regulatory approvals were flagged by some investors/letters as headwinds for order timing, which could pressure near‑term revenue recognition. Softer Than Expected Booking Hurt Itron’s (ITRI) Shares in Q4
• Negative Sentiment: Insider selling and institutional position reductions were noted in recent disclosures, which some investors may view as de‑risking by insiders and large holders. Itron shares rise after Q4 profit surge, strong cash flow, and 2026 outlook (insider/hedge fund data)

Insider Activity at Itron

In other Itron news, SVP Christopher E. Ware sold 343 shares of the company’s stock in a transaction that occurred on Monday, November 24th. The shares were sold at an average price of $96.51, for a total value of $33,102.93. Following the transaction, the senior vice president owned 18,774 shares in the company, valued at approximately $1,811,878.74. This represents a 1.79% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP John F. Marcolini sold 553 shares of Itron stock in a transaction on Monday, November 24th. The shares were sold at an average price of $96.51, for a total transaction of $53,370.03. Following the sale, the senior vice president directly owned 13,843 shares of the company’s stock, valued at $1,335,987.93. This trade represents a 3.84% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders have sold 3,113 shares of company stock worth $301,678. Company insiders own 1.45% of the company’s stock.

Institutional Investors Weigh In On Itron

A number of large investors have recently bought and sold shares of the business. Employees Retirement System of Texas bought a new stake in shares of Itron during the 3rd quarter worth about $32,000. Northwestern Mutual Wealth Management Co. lifted its holdings in Itron by 29.5% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 443 shares of the scientific and technical instruments company’s stock worth $41,000 after purchasing an additional 101 shares during the last quarter. Advisory Services Network LLC bought a new stake in Itron during the third quarter worth approximately $49,000. EverSource Wealth Advisors LLC grew its holdings in Itron by 25.3% during the second quarter. EverSource Wealth Advisors LLC now owns 401 shares of the scientific and technical instruments company’s stock valued at $53,000 after purchasing an additional 81 shares during the last quarter. Finally, UMB Bank n.a. raised its position in shares of Itron by 271.6% in the fourth quarter. UMB Bank n.a. now owns 732 shares of the scientific and technical instruments company’s stock valued at $68,000 after purchasing an additional 535 shares during the period. 96.19% of the stock is currently owned by institutional investors.

About Itron

Itron, Inc (NASDAQ: ITRI) is a global technology company that develops innovative solutions to measure, manage and analyze the use of energy and water. Its comprehensive portfolio includes smart meters, data collection devices, communication networks and advanced software applications designed to optimize utility operations and foster sustainable resource management. The company’s offerings enable utilities and cities to accurately monitor consumption patterns, streamline billing processes and improve grid reliability.

Itron’s product lineup spans a range of hardware and software solutions, from residential and commercial smart meters to meter data management systems (MDMS), networked communication platforms and analytics tools.